Gotham Asset Management LLC cut its holdings in shares of Humana Inc. (NYSE:HUM) by 90.0% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 2,748 shares of the insurance provider’s stock after selling 24,753 shares during the quarter. Gotham Asset Management LLC’s holdings in Humana were worth $1,152,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also added to or reduced their stakes in the company. Jacobi Capital Management LLC boosted its position in shares of Humana by 271.4% during the first quarter. Jacobi Capital Management LLC now owns 78 shares of the insurance provider’s stock valued at $33,000 after buying an additional 57 shares during the last quarter. Childress Capital Advisors LLC purchased a new position in shares of Humana during the 4th quarter valued at about $33,000. AdvisorNet Financial Inc lifted its position in shares of Humana by 54.5% during the 1st quarter. AdvisorNet Financial Inc now owns 85 shares of the insurance provider’s stock valued at $36,000 after buying an additional 30 shares in the last quarter. TCI Wealth Advisors Inc. lifted its position in shares of Humana by 95.7% during the 1st quarter. TCI Wealth Advisors Inc. now owns 90 shares of the insurance provider’s stock valued at $38,000 after buying an additional 44 shares in the last quarter. Finally, CVA Family Office LLC purchased a new position in shares of Humana during the 1st quarter valued at about $50,000. 92.04% of the stock is currently owned by institutional investors.
HUM opened at $463.48 on Thursday. The company has a market cap of $59.79 billion, a price-to-earnings ratio of 21.92, a price-to-earnings-growth ratio of 1.62 and a beta of 0.89. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.43. Humana Inc. has a 12 month low of $370.22 and a 12 month high of $475.44. The stock has a fifty day moving average of $442.24.
Several analysts recently issued reports on HUM shares. Oppenheimer lifted their target price on Humana from $460.00 to $480.00 and gave the company an “outperform” rating in a research note on Thursday, April 29th. Seaport Res Ptn reaffirmed a “neutral” rating on shares of Humana in a research note on Friday, July 9th. Wells Fargo & Company started coverage on Humana in a research note on Monday, May 24th. They issued an “equal weight” rating and a $472.00 price objective on the stock. JPMorgan Chase & Co. lifted their price objective on Humana from $440.00 to $514.00 and gave the stock an “overweight” rating in a research note on Friday, July 9th. Finally, Seaport Global Securities initiated coverage on Humana in a report on Friday, July 9th. They issued a “neutral” rating and a $455.65 target price for the company. Five analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $480.65.
In other news, insider Timothy Alan Wheatley sold 8,508 shares of the stock in a transaction dated Monday, May 3rd. The stock was sold at an average price of $450.59, for a total value of $3,833,619.72. Following the transaction, the insider now directly owns 11,494 shares of the company’s stock, valued at $5,179,081.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Christopher H. Hunter sold 5,156 shares of the stock in a transaction dated Thursday, April 29th. The shares were sold at an average price of $443.76, for a total value of $2,288,026.56. Following the completion of the transaction, the insider now directly owns 8,653 shares in the company, valued at $3,839,855.28. The disclosure for this sale can be found here. Corporate insiders own 0.40% of the company’s stock.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Story: Stop Order Uses For Individual Investors
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.